Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2005 by National Institute on Drug Abuse (NIDA).
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00051896
First received: January 17, 2003
Last updated: April 25, 2012
Last verified: March 2005

January 17, 2003
April 25, 2012
August 2002
Not Provided
Pharmacokinetic parameter comparison
Same as current
Complete list of historical versions of study NCT00051896 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1
Double-Blind, Placebo-Controlled, Dose Escalating, Safety and Pharmacology Study With Three Dosages of GBR 12909 in Cocaine Experienced Volunteers

The purpose of this study is to assess the potential interactions between iv cocaine and GBR 12909.

This is a single dose with escalation, double-blind, placebo-controlled inpatient study in which 24 cocaine experienced volunteers that meet protocol eligibility criteria during a 30 day screen period will be randomized into three dose groups.

Interventional
Phase 1
Masking: Double-Blind
Primary Purpose: Treatment
Cocaine-Related Disorders
Drug: GBR 12909
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
24
Not Provided
Not Provided

Inclusion Criteria:

  • Must understand study procedures and provide written informed consent
  • For additional inclusion criteria information, please contact study site for more information.

Exclusion Criteria:

  • Please contact study site for more information.
Both
18 Years to 45 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00051896
NIDA-CPU-0002-1
Not Provided
Not Provided
National Institute on Drug Abuse (NIDA)
Not Provided
Principal Investigator: Louis Cantilena, M.D. Uniformed Services University of Health Science
National Institute on Drug Abuse (NIDA)
March 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP